Company intelligence / Profile preview
iCamuno Biotherapeutics
Australiaicamunobio.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
The company has multiple programs in development, with ICA01 for solid tumors in IIT Clinical stage. Other programs are in various stages from discovery to IND-enabling.
- Therapeutic areas
- OncologyRheumatologyOphthalmologyNeurology
- Modalities
- Cell therapyiPSC (induced pluripotent stem cell) therapyGene editing
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
The University of Western AustraliaMonash UniversityI Peace
Beyond the preview
Go deeper on iCamuno Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iCamuno Biotherapeutics.